These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
309 related articles for article (PubMed ID: 38406325)
1. The Hippo-YAP Signaling Pathway in Osteoarthritis and Rheumatoid Arthritis. Li M; Zhang FJ; Bai RJ J Inflamm Res; 2024; 17():1105-1120. PubMed ID: 38406325 [TBL] [Abstract][Full Text] [Related]
2. The roles of the Hippo-YAP signalling pathway in Cartilage and Osteoarthritis. Sun K; Guo J; Guo Z; Hou L; Liu H; Hou Y; He J; Guo F; Ye Y Ageing Res Rev; 2023 Sep; 90():102015. PubMed ID: 37454824 [TBL] [Abstract][Full Text] [Related]
3. The role of YAP/TAZ on joint and arthritis. Lu M; Zhu M; Wu Z; Liu W; Cao C; Shi J FASEB J; 2024 May; 38(10):e23636. PubMed ID: 38752683 [TBL] [Abstract][Full Text] [Related]
4. YAP/TAZ: Key Players for Rheumatoid Arthritis Severity by Driving Fibroblast Like Synoviocytes Phenotype and Fibro-Inflammatory Response. Caire R; Audoux E; Courbon G; Michaud E; Petit C; Dalix E; Chafchafi M; Thomas M; Vanden-Bossche A; Navarro L; Linossier MT; Peyroche S; Guignandon A; Vico L; Paul S; Marotte H Front Immunol; 2021; 12():791907. PubMed ID: 34956224 [TBL] [Abstract][Full Text] [Related]
5. Leonurine alleviates rheumatoid arthritis by regulating the Hippo signaling pathway. Ma XN; Feng W; Li N; Chen SL; Zhong XQ; Chen JX; Lin CS; Xu Q Phytomedicine; 2024 Jan; 123():155243. PubMed ID: 38056147 [TBL] [Abstract][Full Text] [Related]
6. Non-hippo kinases: indispensable roles in YAP/TAZ signaling and implications in cancer therapy. Zhu J; Wu T; Lin Q Mol Biol Rep; 2023 May; 50(5):4565-4578. PubMed ID: 36877351 [TBL] [Abstract][Full Text] [Related]
7. Physiological and pathological roles of the Hippo-YAP/TAZ signaling pathway in liver formation, homeostasis, and tumorigenesis. Nishina H Cancer Sci; 2022 Jun; 113(6):1900-1908. PubMed ID: 35349740 [TBL] [Abstract][Full Text] [Related]
8. Resolvin D1 inhibits the proliferation of osteoarthritis fibroblast-like synoviocytes through the Hippo-YAP signaling pathway. Su S; Jiang W; Wang X; Du S; Qi J; Jia Q; Song H BMC Musculoskelet Disord; 2022 Feb; 23(1):149. PubMed ID: 35168589 [TBL] [Abstract][Full Text] [Related]
9. The Hippo-YAP/TAZ Signaling Pathway in Intestinal Self-Renewal and Regeneration After Injury. Deng F; Wu Z; Zou F; Wang S; Wang X Front Cell Dev Biol; 2022; 10():894737. PubMed ID: 35927987 [TBL] [Abstract][Full Text] [Related]
10. Knockdown of YAP/TAZ Inhibits the Migration and Invasion of Fibroblast Synovial Cells in Rheumatoid Arthritis by Regulating Autophagy. Zhou W; Shen Q; Wang H; Yang J; Zhang C; Deng Z; Wu K; Zhou Y; Zeng J; Zhang Y; Shen W J Immunol Res; 2020; 2020():9510594. PubMed ID: 33145365 [TBL] [Abstract][Full Text] [Related]
11. Targeting the Hippo Signaling Pathway for Tissue Regeneration and Cancer Therapy. Juan WC; Hong W Genes (Basel); 2016 Aug; 7(9):. PubMed ID: 27589805 [TBL] [Abstract][Full Text] [Related]
12. TAZ Protein Accumulation Is Negatively Regulated by YAP Abundance in Mammalian Cells. Finch-Edmondson ML; Strauss RP; Passman AM; Sudol M; Yeoh GC; Callus BA J Biol Chem; 2015 Nov; 290(46):27928-38. PubMed ID: 26432639 [TBL] [Abstract][Full Text] [Related]
13. MicroRNAs Regulating Hippo-YAP Signaling in Liver Cancer. Lee NH; Kim SJ; Hyun J Biomedicines; 2021 Mar; 9(4):. PubMed ID: 33808155 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of YAP with siRNA prevents cartilage degradation and ameliorates osteoarthritis development. Gong Y; Li SJ; Liu R; Zhan JF; Tan C; Fang YF; Chen Y; Yu B J Mol Med (Berl); 2019 Jan; 97(1):103-114. PubMed ID: 30465058 [TBL] [Abstract][Full Text] [Related]
15. Roles of Hippo-YAP/TAZ signalling in intervertebral disc degeneration. Zheng-Wei S; Yuan T; Chao-Shuai F; Lei Z; Zong-Rang S; Tuan-Jiang L; Ding-Jun H Biomed Pharmacother; 2023 Mar; 159():114099. PubMed ID: 36641923 [TBL] [Abstract][Full Text] [Related]
16. GRK2 mediated degradation of SAV1 initiates hyperplasia of fibroblast-like synoviocytes in rheumatoid arthritis. Guo P; Jiang J; Chu R; He F; Ge M; Fang R; Guan Q; Cheng H; Jiang C; Su T; Zhu Z; Liu H; Wei W; Zhang S; Wang Q Acta Pharm Sin B; 2024 Mar; 14(3):1222-1240. PubMed ID: 38486990 [TBL] [Abstract][Full Text] [Related]
17. Vestigial-like family member 3 (VGLL3), a cofactor for TEAD transcription factors, promotes cancer cell proliferation by activating the Hippo pathway. Hori N; Okada K; Takakura Y; Takano H; Yamaguchi N; Yamaguchi N J Biol Chem; 2020 Jun; 295(26):8798-8807. PubMed ID: 32385107 [TBL] [Abstract][Full Text] [Related]
18. New insights into the ambivalent role of YAP/TAZ in human cancers. Luo J; Deng L; Zou H; Guo Y; Tong T; Huang M; Ling G; Li P J Exp Clin Cancer Res; 2023 May; 42(1):130. PubMed ID: 37211598 [TBL] [Abstract][Full Text] [Related]
19. Reciprocal regulation of YAP/TAZ by the Hippo pathway and the Small GTPase pathway. Jang JW; Kim MK; Bae SC Small GTPases; 2020 Jul; 11(4):280-288. PubMed ID: 29457552 [TBL] [Abstract][Full Text] [Related]
20. Regulation of ferroptosis in cancer cells by YAP/TAZ and Hippo pathways: The therapeutic implications. Sun T; Chi JT Genes Dis; 2021 May; 8(3):241-249. PubMed ID: 33997171 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]